Rhinoscleroma is a chronic progressive granulomatous condition due to Klebsiella rhinoscleromatis.' In severe cases the typical nodular lesions may extend from the nasopharynx into the respiratory tract and be refractory to antibiotics. We are currently investigating the use of laser treatment for lesions in the trachea and major bronchi. 
Dl8scIon
Rhinoscleroma is a chronic progressive granulomatous condition first described in 1870. 4 It affects the nose and may spread to the pharynx, larynx, trachea, and major bronchi. The condition is rare in Britain but endemic in Eastern Europe, including Hungary, Poland, and the Ukraine; it also occurs in Egypt, north and central Africa, Pakistan, Indonesia, and central America.
The disease is associated with K rhinosckeromads. This organism is found in the cytoplasm of large macrophages (Mikulicz cells) in the subepithelial tissues and some cases respond to treatment with antibiotics-for example, streptomycin and terramycin. Attempts to reproduce the disease experimentally, however, have given conflicting results and it is not certain whether the organism is the sole cause of the condition. Secondary infection is common, and in addition to blockage of the airways patients may complain of purulent nasal discharge and-if the condition spreads beyond the nose-of cough and sputum. Early results suggest that laser treatment via the fibreoptic bonchoscope can be effective palliative treatment for carcinoma of the trachea and major bronchi.2' The principal advantages of this form of treatment are, firstly, the minimal disturbance to the patient, treatment being given under local anaesthetic and so causing little more disturbance than routine fibreoptic bronchoscopy; secondly, the fact that there is no dose limit either in a given session or cumulatively; and, thirdly, the possibility of giving the treatment after other methods have failed. The 
